Pulse cyclophosphamide therapy in frequently relapsing nephrotic syndrome

Nephrology Dialysis Transplantation

Volumn 16, Issue 10, 2001, Pages 2013-2017

  Gulati, Sanjeev ^a   Pokhariyal, Saurabh ^a   Sharma, Raj Kumar ^a   Elhence, Ravi ^a   Kher, Vijay ^a   Pandey, Chander Mohan ^a   Gupta, Amit ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cyclophosphamide; Frequent relapses; Nephrotic syndrome

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CYCLOPHOSPHAMIDE; METOCLOPRAMIDE; PREDNISOLONE; PREDNISONE; SERUM ALBUMIN; STEROID;

ALOPECIA; ARTICLE; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DEPENDENCE; DRUG EFFICACY; DRUG PULSE THERAPY; DRUG RESPONSE; DRUG SAFETY; DRUG SENSITIVITY; EVALUATION; FEMALE; HEMORRHAGIC CYSTITIS; HISTORY; HUMAN; IDIOPATHIC DISEASE; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; NEPHROTIC SYNDROME; PATIENT COMPLIANCE; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA; RELAPSE; REMISSION;

EID: 0034786124     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.10.2013     Document Type: Article

References (20)

1. Steroid response pattern in Indian children with nephrotic syndrome
2. Minimal change nephrotic syndrome, diffuse mesangial hypercellularity and focal glomerular sclerosis
3. Long term effects of immunosuppressants in steroid dependant nephrotic syndrome
4. Minimal change nephrotic syndrome and cyclophosphamide
5. Intravenous pulse cyclophosphamide treatment of lupus nephritis: A prospective five year study
6. Therapy of lupus nephritis. Controlled trial of prednisolone and cytotoxic drugs
7. Side effects of intravenous cyclophosphamide pulse therapy
8. Reduced gonadal toxicity after IV cyclophosphamide administration in patients with non malignant disease
9. Intravenous pulse cyclosphosphamide-a new regime for steroid resistant minimal change nephrotic syndrome
10. Treatment of nephrotic syndrome
11. Pattern of response to prednisolone in idiopathic minimal lesion nephrotic syndrome as a criterion in selecting patients for cyclophosphamide therapy
12. Cyclophosphamide therapy in frequently relapsing nephrotic syndrome with and without steroid dependance
13. Treatment of steroid dependent nephrotic syndrome: Comparison of 8 weeks with 12 week course
14. Eight and twelve week courses of cyclophosphamide in nephrotic syndrome
15. Long term follow up of patients with steroid dependent minimal change nephrotic syndrome
16. Cyclophosphamide in treatment of minimal change nephrotic syndrome
17. Minimal change and focal glomerular sclerosis
18. Pulse cyclophosphamide for steroid resistant FSGS
19. Cyclophosphamide pulse therapy in frequently relapsing nephrotic syndrome
20. Cyclophosphamide pulse therapy in frequently relapsing nephrotic syndrome